GlassScriptPhysician profile
Kaustubh Prabhu
NPI 1083176036
$397.92
in general payments reported to CMS, 2019-2025
12 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.76 · 2023: $16.38 · 2024: $158 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $79.89 | 2024-2025 | Veozah |
| Organon LLC | $70.04 | 2022-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $57.77 | 2025 | |
| Mayne Pharma Commercial LLC | $46.98 | 2024-2025 | |
| Gynesonics, INC. | $29.38 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $19.83 | 2024 | Aptima |
| Sumitomo Pharma America, INC. | $16.42 | 2025 | Myfembree |
| Abbvie INC. | $16.38 | 2023 | |
| Millicent US INC | $16.11 | 2025 | Femlyv |
| Exeltis, USA INC. | $16.00 | 2024 | Slynd |
| Sage Therapeutics, LLC | $14.79 | 2024 | |
| Coopersurgical, INC. | $14.33 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaustubh Prabhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.